Analyst Target Cuts Impact MedTech and Biotech Stocks

Several MedTech and Biotech companies, including TransMedics Group, Insulet Corporation, and Regeneron Pharmaceuticals, have seen their stock price targets cut by analysts. This raises questions about their continued growth opportunities in the respective sectors.